Table A1.
Guideline for Adverse Event Subsampling for Oncology Trials With ≥ 800 Patients to Achieve Similar Power to That of a 400-Patient Subsample of an 800-Patient Trial (specified power approach)
Total Study Size (1:1) | Total Subsample Size (1:1) |
---|---|
800 | 400 |
1,200 | 500 |
1,500 | 590 |
2,000 | 680 |
3,000 | 780 |
6,000 | 890 |